Demeclocycline Hydrochloride 150mg Capsules Ref.[2725] Active ingredients: Demeclocycline

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2012  Publisher: Mercury Pharmaceuticals Ltd No. 1 Croydon 12-16 Addiscombe Road Croydon CR0 0XT UK

Product name and form

Ledermycin Capsules 150mg.

Demeclocycline Hydrochloride 150mg Capsules.

Pharmaceutical Form

Capsule, hard.

Qualitative and quantitative composition

LEDERMYCIN capsules each contain 150mg of demeclocycline hydrochloride.

Active Ingredient Description
Demeclocycline

Tetracyclines have a broad spectrum of anti-microbial activity and act by interfering with bacterial protein synthesis. They are active against a large number of gram positive and gram negative pathogenic bacteria, including some which are resistant to penicillin.

List of Excipients

Cellulose (Elcema G250)
Magnesium stearate
Colloidal silicon dioxide (Aerosil 200)

Capsule body and cap:

Titanium dioxide (E171)
Yellow iron oxide (E172)
Red iron oxide (El72)
Erythrosine (El27)
Gelatin

Printing on capsule:

Shellac glaze
N-Butyl alcohol
Purified water
Propylene glycol (E1520)
Industrial Methylated Spirit
Isopropyl Alcohol
Black iron oxide (E172)

Pack sizes and marketing

Polypropylene containers - 20, 28 or 100 capsules.

Screw capped glass bottles - 100 capsules.

Blister pack - 20 capsules.

HDPE ø 45 mm round 50 ml plastic container containing 28 capsules.

Marketing authorization holder

Mercury Pharmaceuticals Ltd
No. 1 Croydon
12-16 Addiscombe Road
Croydon CR0 0XT
UK

Marketing authorization dates and numbers

PL 12762/0154

8 March 2004

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.